70 articles, transcripts, and reports
The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming. Abbott Laboratories (NYSE:…
Abbott Laboratories (NYSE: ABT) Q3 2021 Earnings Conference
Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Robert B.…
Abbott Laboratories (NYSE: ABT) Q2 2021 Earnings Conference
Abbott Laboratories (NYSE: ABT) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Scott Michael Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Robert…
Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis, sales growth was…
Abbott (NYSE: ABT) Q1 2021 Earnings Conference
The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services. However, in a sign that…
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President and…
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President…
